Abstract
Biosimilars are copies of biological products. They are complex molecular structures hard—if not impossible—to produce by chemical synthesis. One of this complexity’s consequence resides in the analytical techniques for the study of various structural aspects of the molecule population of interest. Powerful physico-chemical and biological methods have to be used in order to globally apprehend the molecules tridimensional integrity and ensure a therapeutic activity and a tolerance profile constant for each patient. Another complexity of these biological substances is found in the production process, an element of their characterisation. This process should be perfectly mastered in spite of variables inherent to the particular mode of expression of genetically engineered substances. In this chapter this complexity’s various elements are studied, with recombinant proteins taken as typical molecules.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsNotes
- 1.
“Recombinant” means a foreign DNA integration into the genome of a host that becomes genetically modified.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag France
About this chapter
Cite this chapter
Ho, K., Trouvin, JH. (2013). Biologicals’ Characteristics. In: Prugnaud, JL., Trouvin, JH. (eds) Biosimilars. Springer, Paris. https://doi.org/10.1007/978-2-8178-0336-4_1
Download citation
DOI: https://doi.org/10.1007/978-2-8178-0336-4_1
Published:
Publisher Name: Springer, Paris
Print ISBN: 978-2-8178-0335-7
Online ISBN: 978-2-8178-0336-4
eBook Packages: MedicineMedicine (R0)